Subchondral bone microenvironment in osteoarthritis and pain

Y Hu, X Chen, S Wang, Y Jing, J Su - Bone research, 2021 - nature.com
Osteoarthritis comprises several joint disorders characterized by articular cartilage
degeneration and persistent pain, causing disability and economic burden. The incidence of …

Emerging pharmaceutical therapies for osteoarthritis

A Latourte, M Kloppenburg, P Richette - Nature Reviews Rheumatology, 2020 - nature.com
The prevalence of osteoarthritis (OA) and the burden associated with the disease are
steadily increasing worldwide, representing a major public health challenge for the coming …

Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression

H Zhang, L Wang, J Cui, S Wang, Y Han, H Shao… - Science …, 2023 - science.org
Abnormal subchondral bone remodeling featured by overactivated osteoclastogenesis
leads to articular cartilage degeneration and osteoarthritis (OA) progression, but the …

Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis

W Hu, Y Chen, C Dou, S Dong - Annals of the Rheumatic Diseases, 2021 - ard.bmj.com
Osteoarthritis (OA) is a degenerative joint disease in the elderly. Although OA has been
considered as primarily a disease of the articular cartilage, the participation of subchondral …

Roles of mechanosensitive channel Piezo1/2 proteins in skeleton and other tissues

L Qin, T He, S Chen, D Yang, W Yi, H Cao, G Xiao - Bone Research, 2021 - nature.com
Mechanotransduction is a fundamental ability that allows living organisms to receive and
respond to physical signals from both the external and internal environments. The …

miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in …

J Wu, L Kuang, C Chen, J Yang, WN Zeng, T Li… - Biomaterials, 2019 - Elsevier
Osteoarthritis (OA) is the most common disabling joint disease throughout the world and its
therapeutic effect is still not satisfactory in clinic nowadays. Recent studies showed that the …

[HTML][HTML] Recent advances in the treatment of osteoarthritis

S Grässel, D Muschter - F1000Research, 2020 - ncbi.nlm.nih.gov
Osteoarthritis (OA) is one of the most debilitating diseases and is associated with a high
personal and socioeconomic burden. So far, there is no therapy available that effectively …

Magnesium‐encapsulated injectable hydrogel and 3D‐engineered polycaprolactone conduit facilitate peripheral nerve regeneration

Z Yao, W Yuan, J Xu, W Tong, J Mi, PC Ho… - Advanced …, 2022 - Wiley Online Library
Peripheral nerve injury is a challenging orthopedic condition that can be treated by autograft
transplantation, a gold standard treatment in the current clinical setting. Nevertheless, limited …

Osteoarthritis pain

H Yu, T Huang, WW Lu, L Tong, D Chen - International Journal of …, 2022 - mdpi.com
Joint pain is the hallmark symptom of osteoarthritis (OA) and the main reason for patients to
seek medical assistance. OA pain greatly contributes to functional limitations of joints and …

Exosomes: roles and therapeutic potential in osteoarthritis

Z Ni, S Zhou, S Li, L Kuang, H Chen, X Luo, J Ouyang… - Bone research, 2020 - nature.com
Exosomes participate in many physiological and pathological processes by regulating cell–
cell communication, which are involved in numerous diseases, including osteoarthritis (OA) …